Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure
Clinical trial NCT02352285 · TERMINATED
Trial details
- NCT number
- NCT02352285
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2017-01-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.